David H. Wesorick, MD; Vineet Chopra, MD, MSc
Disclosures: Dr. Chopra reports grants from the Agency for Healthcare Research and Quality. Dr. Wesorick has disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M16-1400.
Several prescribing practices improved after the publication of the CDC guideline, including the overall rate of opioid prescribing, the rate of prescription of high-dose opioids, and the rate of coprescription of opioids and benzodiazepines.
These results suggest that the publication of the CDC's opioid guideline (and the associated educational campaign) did have a positive effect on opioid prescribing practices in the United States.
This workshop concluded that all patients with infections that might be associated with OUD should be screened for OUD using such tools as the Rapid Opioid Dependence Screen.
The authors also suggested that hospitals should restructure their practices to initiate effective medical treatment for OUD (e.g., buprenorphine, methadone, or naloxone) before hospital discharge and to create adequate systems for postdischarge follow-up, echoing the suggestions from a previous Inpatient Notes.
This workshop provides yet another call for hospitals to take a proactive role in addressing the current opioid crisis.
There is a relatively limited body of scientific evidence defining the risks and benefits of marijuana smoking, but recent changes in state laws have made marijuana more readily available to the public.
These survey results suggest that many Americans' views on marijuana are more favorable than existing evidence supports.
Wesorick DH, Chopra V. Annals for Hospitalists - 18 September 2018. Ann Intern Med. 2018;169:HO1. doi: https://doi.org/10.7326/AFHO201809180
Download citation file:
Published: Ann Intern Med. 2018;169(6):HO1.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use